このエントリーをはてなブックマークに追加
ID 66558
フルテキストURL
fulltext.pdf 10.8 MB
著者
Abe, Masaya Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Asada, Noboru Department of Hematology and Oncology, Okayama University Hospital Kaken ID researchmap
Kimura, Maiko Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Fukui, Chie Division of Hematology, Department of Medicine, Kobe University Hospital
Yamada, Daisuke Department of Regenerative Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Wang, Ziyi Department of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Miyake, Masayuki Division of Medical Support, Okayama University Hospital
Takarada, Takeshi Department of Regenerative Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Ono, Mitsuaki Department of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID researchmap
Aoe, Michinori Division of Medical Support, Okayama University Hospital
Kitamura, Wataru Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Matsuda, Masayuki Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Moriyama, Takashi Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Matsumura, Akifumi Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Maeda, Yoshinobu Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID researchmap
抄録
T-cell acute leukemia and lymphoma have a poor prognosis. Although new therapeu-tic agents have been developed, their therapeutic effects are suboptimal. α- Pinene, a monoterpene compound, has an antitumor effect on solid tumors; however, few comprehensive investigations have been conducted on its impact on hematologic ma-lignancies. This report provides a comprehensive analysis of the potential benefits of using α- pinene as an antitumor agent for the treatment of T-cell tumors. We found that α- pinene inhibited the proliferation of hematologic malignancies, especially in T- cell tumor cell lines EL-4 and Molt-4, induced mitochondrial dysfunction and re-active oxygen species accumulation, and inhibited NF-κB p65 translocation into the nucleus, leading to robust apoptosis in EL-4 cells. Collectively, these findings suggest that α- pinene has potential as a therapeutic agent for T-cell malignancies, and further investigation is warranted.
キーワード
alpha-pinene
apoptosis
hematologic malignancies
lymphoblastic leukemia, acute, T-cell
T-cell lymphoma
発行日
2024-01-26
出版物タイトル
Cancer Science
115巻
4号
出版者
Wiley
開始ページ
1317
終了ページ
1332
ISSN
1347-9032
NCID
AA11808050
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
© 2024 The Authors.
論文のバージョン
publisher
PubMed ID
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.1111/cas.16086
ライセンス
https://creativecommons.org/licenses/by-nc-nd/4.0/
Citation
Abe M, Asada N, Kimura M, et al. Antitumor activity of α-pinene in T-cell tumors. Cancer Sci. 2024; 115: 1317-1332. doi:10.1111/cas.16086
助成機関名
Wesco Scientific Promotion Foundation
Teraoka Scholarship Foundation